Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

59.10
-0.5400-0.91%
Volume:542.42K
Turnover:32.23M
Market Cap:11.33B
PE:21.85
High:60.16
Open:59.96
Low:58.86
Close:59.64
Loading ...
May 31, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
Apr 29, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2022

Major Issues Report

8-K - Current report
Feb 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 28, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 30, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities